Young-Joon Ko

Dr. Young-Joon Ko

Animal and Plant Quarantine Agency, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
JPJong-Hyeon Park
Jong-Hyeon Park
DTDONGSEOB TARK
DONGSEOB TARK
KLKwang-Nyeong Lee
Kwang-Nyeong Lee
SLSeo-Yong Lee
Seo-Yong Lee
MKMi-Kyeong Ko
Mi-Kyeong Ko
BKByounghan Kim
Byounghan Kim
Park JH, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):83-87. https://doi.org/10.7774/cevr.2016.5.1.83

13 May 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
SPSoonyong Park
Soonyong Park
JKJi Yul Kim
Ji Yul Kim
KRKyoung-Hwa Ryu
Kyoung-Hwa Ryu
AKAh-Young Kim
Ah-Young Kim
Kim JaemunKim Jaemun
Kim Jaemun
ELEun Gyo Lee
Eun Gyo Lee
The baby hamster kidney-21 (BHK-21) cell line is a continuous cell line used to propagate foot-and-mouth disease (FMD) virus for vaccine manufacturing. BHK-21 cells are anchorage-dependent, although suspension cultures would enable rapid growth in bioreactors, large-scale virus propagation, and cost-effective vaccine production with serum-free medium. Here, we report the successful adaptation of adherent BHK-21 cells to growth in suspension to a viable cell density of 7.65 × 106 cells/mL on day 3 in serum-free culture medium. The suspension-adapted BHK-21 cells showed lower adhesion to five types of extracellular matrix proteins than adherent BHK-21 cells, which contributed to the suspension culture. In addition, a chemically defined medium (selected by screening various prototype media) led to increased FMD virus production yields in the batch culture, even at a cell density of only 3.5 × 106 cells/mL. The suspension BHK-21 cell culture could be expanded to a 200 L bioreactor from a 20 mL flask, which resulted in a comparable FMD virus titer. This platform technology improved virus productivity, indicating its potential for enhancing FMD vaccine production.

29 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
HKHyejin Kim
Hyejin Kim
AKAh-Young Kim
Ah-Young Kim
JCJieun Choi
Jieun Choi
SPSun Young Park
Sun Young Park
SPSANG HYUN PARK
SANG HYUN PARK
YKYoung-Joon Ko
Young-Joon Ko
Foot-and-mouth disease (FMD) is a highly contagious disease caused by FMD virus (FMDV) in cloven-hoofed animals. Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are representative receptors in the cytoplasm for the detection of viral RNA and trigger antiviral responses, leading to the production of type I interferon. Although MDA5 is a crucial receptor for sensing picornavirus RNA, the interplay between MDA5 and FMDV is relatively unknown compared to the interplay between RIG-I and FMDV. Here, we observed that the FMDV infection inhibits MDA5 protein expression. Of the non-structural proteins, the Lb and 3C proteinases (Lbpro and 3Cpro) were identified to be primarily responsible for this inhibition. However, the inhibition by 3Cpro was independent of proteasome, lysosome and caspase-dependent pathway and was by 3C protease activity. A direct interaction between 3Cpro and MDA5 protein was observed. In conclusion, this is the first report that 3Cpro inhibits MDA5 protein expression as a mechanism to evade the innate immune response during FMDV infection. These results elucidate the pathogenesis of FMDV and provide fundamental insights for the development of a novel vaccine or therapeutic agent.

1 January 2012 in Journal of Virological Methods
Verified
Journal Article
Closed access
YKYoung-Joon Ko
Young-Joon Ko
HLHyang-Sim Lee
Hyang-Sim Lee
JPJong-Hyeon Park
Jong-Hyeon Park
KLKwang-Nyeong Lee
Kwang-Nyeong Lee
SKSu-mi Kim
Su-mi Kim
Satya ParidaSatya Parida
Satya Parida

25 May 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
JKJae Young Kim
Jae Young Kim
SPSun Young Park
Sun Young Park
JJJong Sook Jin
Jong Sook Jin
DKDohyun Kim
Dohyun Kim
JPJong-Hyeon Park
Jong-Hyeon Park
YKYoung-Joon Ko
Young-Joon Ko
Foot-and-mouth disease (FMD) vaccines must be produced in a biosafety level 3 facility, so the FMD virus (FMDV) must be completely inactivated after amplification. The inactivation kinetics of FMDV during vaccine antigen production were assessed by evaluating whether the viral titer dropped below 10−7 TCID50/mL within 24 h of binary ethyleneimine (BEI) treatment. This study dealt with four FMD vaccine candidate strains for the efficacy of BEI treatment at different concentrations and temperatures to determine the optimal inactivation condition of each virus. Two domestic isolates, O/SKR/Boeun/2017 (O BE) and A/SKR/Yeoncheon/2017 (A YC), and two recombinant viruses, PAK/44/2008 (O PA-2) and A22/Iraq/24/64 (A22 IRQ), were investigated. The O BE and A22 IRQ required 2 mM BEI at 26 °C and 0.5 mM BEI at 37 °C for complete inactivation. The O PA-2 and A YC required 2 mM BEI at 26 °C and 1 mM BEI at 37 °C. Crucially, the yield of FMD virus particles (146S) in the viral infection supernatant was higher (>4.0 µg/mL) than those previously reported; additionally, there was little antigen loss, even after 24 h of treatment with 3 mM BEI. Overall, it is considered economical to produce FMD vaccines using these four kinds of viruses; therefore, these candidate strains will be prioritized for the manufacture of FMD vaccines in South Korea.

1 July 2019 in Journal of Virological Methods
Verified
Journal Article
Closed access
HKHyejin Kim
Hyejin Kim
AKAh-Young Kim
Ah-Young Kim
JKJae-Seok Kim
Jae-Seok Kim
JLJung-Min Lee
Jung-Min Lee
MKMinhee Kwon
Minhee Kwon
YKYoung-Joon Ko
Young-Joon Ko